Cardiovascular Risk Factors and Cognitive Decline: Insights from Middle-Aged Adults
Cardiovascular risk factors are associated with decreased memory and cognitive function in middle age, highlighting the importance of cardiovascular health promotion in mitigating cognitive decline and dementia risk later in life.
September 2022
Biomarker Validation in Muscle-Invasive Bladder Cancer: Prospective Trial Insights
The first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer treated with chemotherapy provides valuable insights into the clinical utility of biomarkers for prognostication and treatment response prediction, informing personalized management strategies for this aggressive malignancy.
September 2022
Menstruation and COVID-19 Vaccine: Reassuring Observational Data
Two new observational studies provide reassuring data on the safety and efficacy of COVID-19 vaccination in menstruating individuals, addressing concerns and supporting the inclusion of diverse populations in vaccination campaigns.
September 2022
Dental Caries as a Non-Communicable Disease: Pathophysiological Insights
Advances in understanding the human and oral microbiome have led to recognition of dental caries as a non-communicable disease, emphasizing the importance of balancing protective and pathological risk factors in maintaining oral health and preventing dental caries.
September 2022
Casirivimab and Imdevimab Combination Therapy in COVID-19: Mortality Reduction Findings
The monoclonal antibody combination of casirivimab and imdevimab reduces mortality in COVID-19 patients, offering a promising therapeutic option to improve clinical outcomes and reduce the burden of severe disease in high-risk individuals.
September 2022
Blepharitis and Metabolic Syndrome: Epidemiological Insights from Taiwan
A study using health insurance database in Taiwan investigates the relationship between blepharitis and metabolic syndrome, providing epidemiological insights into the association between ocular inflammation and systemic metabolic dysfunction.
September 2022
Metabolic Syndrome and COVID-19 Outcomes: Implications for Disease Burden
Metabolic syndrome is associated with an increased risk of acute respiratory distress syndrome (ARDS) and death from COVID-19, providing insights into the disproportionate impact of COVID-19 on individuals with metabolic comorbidities and underlying cardiometabolic dysfunction.
September 2022
COVID-19 Vaccine Safety in Pregnancy: Reassuring Data from Observational Studies
Reassuring data from observational studies support the safety of the COVID-19 vaccine during pregnancy, providing important insights for pregnant individuals and healthcare providers regarding vaccination decisions and maternal-fetal health outcomes.
September 2022
